Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,976-2,000 of 2,022
CompletedNCT02968602

Minocycline and Tobacco Craving in Smokers With Schizophrenia

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT02118610

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT00492349

Varenicline Adjunctive Treatment in Schizophrenia

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT05179525

Comparative Bioavailability of Risperidone.

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Rovi Pharmaceuticals Laboratories
Condition
Schizophrenia
Active Not RecruitingNCT04829292

Stepped Care for Youth at Risk of Psychosis

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 12 Years to 30 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Schizophrenia
CompletedNCT05227118

Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)

This study exists to better understand the safety of the medication MK-8189 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication MK-8189 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 65 Years to 85 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
RecruitingNCT05847192

Tau Networks in Psychotic Alzheimer's Disease

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 65 Years to 85 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT05114733

Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 22 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
CompletedNCT06567587

Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD

This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can improve sleep, daily rhythms, and longer-term stability.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Egypt
Sponsor
Tanta University
Condition
Schizophrenia
CompletedNCT05310981

A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC)

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Condition
Schizophrenia
CompletedNCT04949542

Bolster: Caregiver App to Reduce Duration of Untreated Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia
Enrolling By InvitationNCT05509998

Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 12 Years to 30 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
Not Yet RecruitingNCT07041463

Psychoeducation Program for Family Caregivers Coordinated by an APRN

This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT04132557

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Enrolling By InvitationNCT06655688

Acceptance and Commitment Therapy (ACT) for Family Members After a First Psychotic Attack

This study exists to see whether acceptance and commitment therapy, a talking treatment, can play a useful role in care. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Saglik Bilimleri Universitesi
Condition
Schizophrenia
CompletedNCT04188366

Improving Family Engagement in Coordinated Specialty Care for First Episode Psychosis

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Washington State University
Condition
Schizophrenia
Not Yet RecruitingNCT06928935

Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 16 Years to 29 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT04889911

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 15 Years to 24 Years
Countries
United States
Sponsor
John Jay College of Criminal Justice, City University of New York
Condition
Schizophrenia
WithdrawnNCT02492074

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
RecruitingNCT06802952

RTMS for CHR Based on Personalized Targets Using Magnetoencephalography

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 13 Years to 35 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT05728138

Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
RecruitingNCT05995782

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherOver 19 Years
Countries
South Korea
Sponsor
1ST Biotherapeutics, Inc.
Condition
Schizophrenia